Products ancillary to ownership of the coin itself can come saddled with significant shortcomings.
I suspect that commodity cost inflation may be the biggest factor that's currently weighing on DNUT.
ProQR Therapeutics, Oscar Health and Hims & Hers Health appear to have promising futures.
Here's why I detect a hole in the charts.
The shares of the initial public offering were priced below their initial expected range but the stock is up nicely from its first-day action.
Life has not been easy for the small-cap biotech investor so far in 2021.
Shares in the e-commerce site leapt by the daily limit in Jakarta, with the company paving a path to public markets.
Plus, taking another look at Robinhood post-IPO and what it says about the modern marketplace.
Imagine if the SEC did not prohibit underwriters from lending out shares to short-sellers for 30 days after an IPO?
The debuts of Robinhood, Krispy Kreme and Dole were less than stellar, but one of the trio might be worth a good look right now.
When we combine the poorly placed HOOD IPO with the startling miss and guidance markdown in Amazon, the stage seems to be set for a correction.
As the Robinhood debacle shows, not much has changed over the decades when it comes to initial public offerings.
The big question is whether everything will be dragged down together or whether there will be some tradable rotation.
Is HOOD walking into the public spotlight with a bulls-eye on its back before it gets a chance to prove itself?
After being burned by Beijing, many U.S. investors are rightfully left wondering about their China-linked holdings.
Robinhood has had a bit of a rough patch on its journey to becoming a public company.
Unlike most recent IPOs, the health information platform company is profitable.
Let's look at the charts of this SPAC.
Strong performance has pushed the Singapore state investor's assets to record levels. But its cross-border scope is increasingly difficult to maintain.
China will require tech companies with more than 1 million users to submit to a formal review before seeking an international listing under new cyberspace rules.
Obsessed with controlling the Big Data held by Chinese tech firms, Beijing cyberspace officials clamp down on U.S. listings that were previously permissible.
However, it's a mystery as to why the holding company enjoyed a 10% bump on Tuesday.
The viciousness of what happened here is extraordinary.
Plus, quick looks at Tesla's car deliveries, Amazon's CEO change and Didi Global's post-IPO downdraft.
Ride-hailing app Didi is among three Chinese companies recently listed on U.S. markets that are being prevented from signing up new users by China's Internet regulator.
The 2021 version seems overpriced, has much to prove, and seems in the 'priced-for-perfection' category.
Issues of concern include a high level of IPOs sopping up liquidity and persistent labor and supply shortages impacting business.
With backing from some of tech's heaviest hitters, Didi or "beep beep" joins Dingdong in going public this week.
The current version of the doughnut purveyor doesn't resemble the business that JAB Holdings acquired five years ago.
It's unusual to find a growth stock with the potential for revenue increases that's already making money.